Citations

Institution: Mayo Clinic Clear

Showing 10 of 108083 citations.

Evaluating prompt and data perturbation sensitivity in large language models for radiology reports classification
Sorin, Vera , Collins, Jeremy D. , Bratt, Alex , Mugu, Vamshi , Kline, Timothy L. , Butler, Charles S. , Cook, Cole J. , Korfiatis, Panagiotis , Bratt, Alex K, Kusmirek, Joanna E. , Butler, Crystal L, Wood, Nadia G, Collins, Jeremy , Wood, Nadia

JAMIA Open | August 8, 2025 | Volume: 8 | Issue: 4 | Pages: No page available

10.1093/jamiaopen/ooaf073 | PMID 40799928 Get It

Abstract Objectives Large language models (LLMs) offer potential in natural language processing tasks in healthcare. Due to the need for high accuracy, understanding their limitations is essential. The purpose of this study was to evaluate the performance of LLMs in classifying radiology reports for the presence of pulmonary embolism (PE) under various conditions, including different prompt designs and data perturbations. Materials and Methods In this retrospective, institutional review board approved study, we evaluated 3 Google’s LLMs including Gemini-1.5-Pro, Gemini-1.5-Flash-001, and Gemini-1.5-Flash-002, in classifying 11 999 pulmonary CT angiography radiology reports for PE. Ground truth labels were determined by concordance between a computer vision-based PE detection (CVPED) algorithm and multiple LLM runs under various configurations. Discrepancies between algorithms’ classifications were aggregated and manually reviewed. We evaluated the effects of prompt design, data perturbations, and repeated analyses across geographic cloud regions. Performance metrics were calculated. Results Of 11 999 reports, 1296 (10.8%) were PE-positive. Accuracy across LLMs ranged between 0.953 and 0.996. The highest recall rate for a prompt modified after a review of the misclassified cases (up to 0.997). Few-shot prompting improved recall (up to 0.99), while chain-of-thought generally degraded performance. Gemini-1.5-Flash-002 demonstrated the highest robustness against data perturbations. Geographic cloud region variability was minimal for Gemini-1.5+-Pro, while the Flash models showed stable performance. Discussion and Conclusion LLMs demonstrated high performance in classifying radiology reports, though results varied with prompt design and data quality. These findings underscore the need for systematic evaluation and validation of LLMs for clinical applications, particularly in high-stakes scenarios.
Connectivity as a universal predictor of tau progression in atypical Alzheimer’s disease
Bruin, Hannah de , Groot, Colin , Barthel, Henryk , Bischof, Gérard N. , Boon, Baayla D.C. , Brendel, Matthias , Cash, David M. , Coath, William , Day, Gregory S. , Dyck, Christopher H. van , Fredericks, Carolyn , Fryer, Tim D. , Graff‐Radford, Jonathan , Hobbs, Diana A. , Hoenig, Merle C. , Josephs, Keith A. , Katsumi, Yuta , Joie, Renaud La , Xiong, Chengjie , Malpetti, Maura , McGinnis, Scott M., Mecca, Adam P. , O’Brien, John T. , Putcha, Deepti , Rabinovici, Gil D. , Rahmouni, Nesrine , Rullmann, Michael , Saur, Dorothee , Servaes, Stijn , Sintini, Irene , Stevenson, Jenna , Stomrud, Erik , Strandberg, Olof, Tideman, Pontus , Touroutoglou, Alexandra , Trainer, Anne, Wekselman, Fattin, Weston, Philip S.J. , Whitwell, Jennifer L. , Yong, Keir , de Bruin, Hannah , Brendel, Matthias , Cash, David M , Coath, William , Dickerson, Bradford Clark , van Eimeren, Thilo , van der Flier, Wiesje M , Fredericks, Carolyn A , Gordon, Brian A , Graff-Radford, Jonathan , Grinberg, Lea , Hansson, Oskar , Irwin, David J , Josephs, Keith A , Katsumi, Yuta , La Joie, Renaud , Lee, Edward B , Xiong, Chengjie , Malpetti, Maura , Mohanty, Rosaleena , O'Brien, John Tiernan , Palleis, Carla , Phillips, Jeffrey S , Putcha, Deepti , Rosa-Neto, Pedro , Schott, Jonathan M , Schroeter, Matthias L , Smith, Ruben , Spina, Salvatore , Therriault, Joseph , Whitwell, Jennifer , Yong, Keir X X , Franzmeier, Nicolai , Day, Gregory S , Stomrud, Erik , Rabinovici, Gil D , Blazhenets, Ganna , Boellaard, Ronald , Doering, Elena , Drzezga, Alexander E. , Flier, Wiesje M. van der , Giessen, Elsmarieke van de , Gordon, Brian A. , Grinberg, Lea T. , Hansson, Oskar , Höglinger, Günter U. , Irwin, David J. , Jones, Peter Simon , Lee, Edward B. , Mohanty, Rosaleena , Nasrallah, Ilya M. , O’Dell, Ryan S. , Perneczky, Robert , Rowe, James B. , Sabri, Osama , Schildan, Andreas , Schott, Jonathan M. , Seeley, William W. , Servaes, Stijn , Spina, Salvatore , Visser, Denise , Wolk, David A. , Pijnenburg, Yolande A.L. , Franzmeier, Nicolai , Ossenkoppele, Rik

Brain | August 8, 2025 | Volume: 148 | Issue: 11 | Pages: 3893-3912

10.1093/brain/awaf279 | PMID 40810361 Get It

Abstract The link between regional tau load and clinical manifestation of Alzheimer’s disease (AD) highlights the importance of characterizing spatial tau distribution across disease variants. In typical (memory-predominant) AD, the spatial progression of tau pathology mirrors the functional connections from temporal lobe epicentres. However, given the limited spatial heterogeneity of tau in typical AD, atypical (non-amnestic-predominant) AD variants with distinct tau patterns provide a key opportunity to investigate the universality of connectivity as a scaffold for tau progression. In this large-scale, multicentre study across 14 international sites, we included cross-sectional tau-PET data from 320 individuals with atypical AD (n = 139 posterior cortical atrophy/PCA-AD; n = 103 logopenic variant primary progressive aphasia/lvPPA-AD; n = 35 behavioural variant AD/bvAD; n = 43 corticobasal syndrome/CBS-AD), with a subset of individuals (n = 78) having longitudinal tau-PET data. Additionally, as an independent sample, we included regional post-mortem tau stainings from 93 atypical AD patients from two sites (n = 19 PCA-AD, n = 32 lvPPA-AD, n = 23 bvAD, n = 19 CBS-AD). Gaussian mixture modelling was used to harmonize different tau-PET tracers by transforming tau-PET standardized uptake value ratios to tau positivity probabilities (a uniform scale ranging from 0% to 100%). Using linear regression, we assessed whether brain regions with stronger resting-state functional MRI-based functional connectivity, derived from healthy elderly controls in the Alzheimer’s Disease Neuroimaging Initiative (ADNI), showed greater covariance in cross-sectional and longitudinal tau-PET and post-mortem tau pathology. Furthermore, we examined whether functional connectivity of tau-PET epicentres (i.e. the top 5% of regions with the highest baseline tau load) and tau-PET accumulation epicentres (i.e. the top 5% of regions with the highest tau accumulation rates) was associated with cross-sectional and longitudinal tau patterns. Our findings show that tau-PET epicentres aligned with clinical variants, e.g. a visual network predominant pattern in PCA-AD (‘visual AD’) and left-hemispheric temporal predominance, particularly within the language network, in lvPPA-AD (‘language AD’). Moreover, more strongly functionally connected regions showed correlated concurrent tau-PET levels (confirmed with post-mortem data) and tau-PET accumulation rates. The functional connectivity profile of tau-PET epicentres and accumulation epicentres corresponded to tau-PET progression patterns, with higher tau-PET levels and accumulation rates in functionally close regions, and lower tau-PET levels and accumulation rates in functionally distant regions. Our data are consistent with the hypothesis that tau propagation occurs along functional connections originating from local epicentres, across all AD clinical variants. Since tau proteinopathy is a major driver of neurodegeneration and cognitive decline, this finding may advance personalized medicine and participant-specific end points in clinical trials.
A Turning Point for Lipoprotein(a) Treatment: Are Clinical Laboratories Ready?
Donato, Leslie J. , Donato, Leslie

Clinical Chemistry | August 8, 2025 | Volume: 72 | Issue: 2 | Pages: 222-224

10.1093/clinchem/hvaf101 | PMID 40926664 Get It

AAOS 2024 CTS Guidelines—Comments by Members of AANEM CTS Severity Scale Workgroup
Bland, Jeremy D.P. , Rubin, Devon I., Cartwright, Michael, Kincaid, John C., Al‐lawati, Zainab, Grant, Peter , Bland, Jeremy , Rubin, Devon, Robinson, Lawrence R , Robinson, Lawrence R. , Cartwright, Michael, Andary, Michael , Al-Lawati, Zainab J.

Muscle & Nerve | August 8, 2025 | Volume: 72 | Issue: 4 | Pages: 566-569

10.1002/mus.28477 | PMID 40778412 Get It

Insights Into Cigarette Litigation From a Career Tobacco Dependence Physician: The Florida Engle Trials
Hurt, R. Douglas

Journal of Primary Care & Community Health | August 8, 2025 | Volume: 16 | Issue: No issue available | Pages: No page available

10.1177/21501319251363900 | PMID 40776901 Get It

The purpose of this commentary is to better inform physicians about the often-unrecognized consequences of cigarette smoking. It highlights knowledge gained from involvement in over 70 legal cases between smokers and cigarette companies in the Florida Engle Trials. As a physician with many years of experience in treating nicotine addiction, the author participated as a paid expert witness in these cases, 45 of which went to trial. Depositions included family members and close associates of the smoker, which allowed the gathering of voluminous information not usually available to a physician. This provided a level of insight into the suffering experienced that was illuminating. Based on this experience as an expert witness, 3 cases are presented that are clear examples of the tragedy experienced by smokers and their families. While not randomly selected, they are representative of the cases in which I participated. The impact of cigarettes on both smokers and those around them is difficult to quantify and is often not observable by healthcare professionals. The documented attitudes of cigarette lawyers, as seen in depositions and at trials, demonstrate an incredible lack of empathy and compassion. On the other hand, the cigarette companies are completely aware that almost 500 000 Americans die each year from use of their products, but death is only 1 outcome. What a sad commentary on the companies that knowingly perpetuated this epidemic and the lawyers who continue to defend them. Sadly, to both parties, it isn’t about the pain, suffering, morbidity, and death that these products cause. Rather, it is simply about money and staying in business on the one hand and money and winning on the other. However, the paramount lesson learned for all of us who take care of smoking patients is first to help them stop smoking and second to appreciate the wide-reaching ramifications of their tobacco dependence. Taking this empathic approach to their care will go a long way to demonstrating the compassion that is needed to provide a healing environment for the patient, their family, and loved ones.
Preclinical feasibility study for transvascular drainage of non-acute subdural hematomas
Liu, Yang , Madhani, Sarosh Irfan , Larco, Jorge Luis Arturo, Shahid, Adnan Hussain , Şenol, Yiğit Can , Lylyk, Pedro , Arturo Larco, Jorge Luis, Lylyk, Pedro N, Savastano, Luis , Liu, Yang , Shahid, Adnan H , Senol, Yigit Can , Larco, Jorge Arturo

Journal of NeuroInterventional Surgery | August 8, 2025 | Volume: 18 | Issue: 5 | Pages: 1355-1363

10.1136/jnis-2025-023794 | PMID 40780814 Get It

Background Non-acute or chronic subdural hematoma (cSDH) is commonly treated with surgical evacuation followed by middle meningeal artery embolization (MMAe). This two step approach increases procedural complexity and redundancy, hospitalization duration, and patient risk. We hypothesized that cSDH could be managed through a single session endovascular procedure and conducted a multimodal preclinical study to evaluate feasibility. Methods We performed three-dimensional heat mapping of hematoma distribution from preoperative CT scans (n=69) and analyzed middle meningeal artery (MMA) and superior sagittal sinus (SSS) anatomy and perforation trajectories using imaging from 107 patients. Rheological properties of 41 SDH samples were assessed using hybrid rheometry and modeled with the Carreau equation. Aspiration feasibility was tested using a 0.027 inch microcatheter (n=16), and dura perforation forces were quantified with a 28 G needle in fresh cadaveric dura (n=10). Results Heat mapping localized cSDH to the parietal convexities (>80% probability) under the branches of the MMA, with limited midline involvement and proximity to the SSS (<10%). The posterior division of the MMA (diameter 1.23±0.23 mm) accommodated a 0.027 inch microcatheter in >90% of cases, with perforation trajectories targeting high probability hematoma zones in 105 of 107 cases. SDH samples exhibited shear thinning viscosity ( η ₀ =172 mPa×s, η ∞ =2.78 mPa×s), with mean aspiration times of 1.21±0.54 min per 10 mL. Perforation forces averaged 0.68±0.24 N in normal and 1.29±0.48 N in calcified dura (P=0.05). Conclusion Anatomical, rheological, and biomechanical data from this study support the feasibility of endovascular drainage of cSDH through the MMA.
Comment on “Biology and Management of Male‐Bodied Athletes in Elite Female Sports” by Handelsman and Bermon
Brown, Gregory A. , Shaw, Brandon S. , Joyner, Michael J. , Hunter, Sandra K. , Senefeld, Jonathon W. , Lundberg, Tommy R. , Carlson, Chad, Shaw, Brandon , Joyner, Michael J , Hunter, Sandra K , Senefeld, Jonathon W , Lundberg, Tommy R , Shaw, Ina , Tucker, Ross , Hilton, Emma N. , Kirk, Christopher

Drug Testing and Analysis | August 8, 2025 | Volume: 17 | Issue: 11 | Pages: 2271-2273

10.1002/dta.3916 | PMID 40774828 Get It

Positive Predictive Value of Tissue Transglutaminase IgA for Celiac Disease
Wong, Madison , Cárdenas, María C. , Stahl, Marisa G. , Liu, Edwin , Caplan, Mayan, Gidrewicz, Dominica , Leonard, Maureen M. , Pacheco, M. Cristina, Dickerson, Jane A. , Raber, Catherine , Badalyan, Vahe , Chugh, Ankur , Baek, Clara, Singh, Arunjot , Fahey, Lisa M. , Walsh, Catharine M. , Silvester, Jocelyn A. , Absah, Imad , Camila Cardenas, Maria, Silvester, Jocelyn A , Walsh, Catharine M , Chang, Denis , Caplan, Mayan, King, James A. , Turner, Justine , Lee, Dale Young , Setty, Mala , Baek, Clara

Pediatrics | August 8, 2025 | Volume: 156 | Issue: 3 | Pages: No page available

10.1542/peds.2025-070897 | PMID 40774665 Get It

BACKGROUND AND OBJECTIVES Recent changes in European diagnostic criteria allow for serologic diagnosis of celiac disease in children. Those guidelines have not been adopted in North America; hence, we aim to assess the positive predictive value (PPV) of tissue transglutaminase (tTG) immunoglobulin A (IgA) assays used in North America in identifying histologic findings of celiac disease. METHODS Multicenter retrospective cohort study of children (&lt;18 years) with an elevated tTG IgA within 6 months of an esophagogastroduodenoscopy between January 2016 and December 2021. Biopsy-confirmed celiac disease was determined by the presence of intraepithelial lymphocytosis and villous atrophy. The primary outcomes were the PPV of an elevated tTG IgA and tTG IgA greater than or equal to 10 times the upper limit of normal (10× ULN). RESULTS Overall, 4019 children (63.3% female; 9% type 1 diabetes, 2% Down syndrome) were included. Histologic findings were consistent with celiac disease for 3321 children (PPV = 82.6% [95% CI, 81.4–83.8]). Among the 1739/4019 (43.2%) children with tTG IgA greater than or equal to 10× ULN, 1651 had biopsy-confirmed celiac disease (PPV10× = 94.9% [95% CI, 93.8–95.9]). Five percent (88/1739) of children did not have histologic findings of celiac disease, including 41/1739 (2%) with normal histology. Diagnostic accuracy of tTG IgA varied widely among assays used in North America (PPV range: 71.5%–88.8%; PPV10× range: 89.3%–97.3%). Assays performed worse in children with type 1 diabetes (PPV10× 89% [95% CI, 83.5–92.8]). CONCLUSIONS Elevated tTG IgA in isolation is insufficient to confidently diagnose celiac disease. As tTG assay performance varied widely, diagnostic confirmation by a specialist prior to dietary changes is essential.
Financial Implications of Methadone Use in Cardiothoracic Surgery: A Post Hoc Analysis of a Retrospective Cohort
Hand, Brennan , Dholakia, Ruchita, Chapital, Alyssa B. , Milam, Adam J. , Hand, Brennan A , Milam, Adam J , Smith, Bradford B. , Borah, Bijan J.

Anesthesia & Analgesia | August 7, 2025 | Volume: 142 | Issue: 2 | Pages: 419-421

10.1213/ane.0000000000007684 | PMID 40773715 Get It

Management of Glenoid Bone Loss in Primary Reverse Total Shoulder Arthroplasty
Marigi, Erick M. , Vasquez-Loret, Amanda, Baird, M. , Hart, Christopher M. , Sperling, John W. , Sánchez‐Sotelo, Joaquín , Marigi, Erick , Yu, Kristin E. , Vasquez-Loret, Amanda , Baird, Michael D , Hart, Christopher M , Sperling, John W , Sanchez-Sotelo, J.

JBJS Open Access | August 7, 2025 | Volume: 10 | Issue: 3 | Pages: No page available

10.2106/jbjs.oa.25.00131 | PMID 40777213 Get It

Abstract » A thorough understanding of glenoid deformity is essential to anticipate intraoperative needs and manage bony deficiencies. Management strategies include eccentric reaming, alternate scapular line baseplate orientation, bone grafting, or metallic augmentation as either “off-the-shelf” or custom baseplates. Accurate implantation of the glenoid component in the presence of glenoid bone loss (GBL) may also benefit from shoulderspecific guides, navigation, or robotic assistance. » GBL can negatively affect outcomes due to compromised bony fixation, altered soft tissue tensioning, and component malposition, which can contribute to impingement, dislocation, aseptic loosening, polyethylene wear, and component failure. » In this article, we provide a comprehensive review of published literature regarding the management of GBL in primary RSA and provide additional insight on the effectiveness of current approaches to manage bony deficiency.